Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Sep 10;140(11):899-909.
doi: 10.1161/CIRCULATIONAHA.119.041980. Epub 2019 Aug 16.

Machine Learning to Predict the Likelihood of Acute Myocardial Infarction

Affiliations

Machine Learning to Predict the Likelihood of Acute Myocardial Infarction

Martin P Than et al. Circulation. .

Abstract

Background: Variations in cardiac troponin concentrations by age, sex, and time between samples in patients with suspected myocardial infarction are not currently accounted for in diagnostic approaches. We aimed to combine these variables through machine learning to improve the assessment of risk for individual patients.

Methods: A machine learning algorithm (myocardial-ischemic-injury-index [MI3]) incorporating age, sex, and paired high-sensitivity cardiac troponin I concentrations, was trained on 3013 patients and tested on 7998 patients with suspected myocardial infarction. MI3 uses gradient boosting to compute a value (0-100) reflecting an individual's likelihood of a diagnosis of type 1 myocardial infarction and estimates the sensitivity, negative predictive value, specificity and positive predictive value for that individual. Assessment was by calibration and area under the receiver operating characteristic curve. Secondary analysis evaluated example MI3 thresholds from the training set that identified patients as low risk (99% sensitivity) and high risk (75% positive predictive value), and performance at these thresholds was compared in the test set to the 99th percentile and European Society of Cardiology rule-out pathways.

Results: Myocardial infarction occurred in 404 (13.4%) patients in the training set and 849 (10.6%) patients in the test set. MI3 was well calibrated with a very high area under the receiver operating characteristic curve of 0.963 [0.956-0.971] in the test set and similar performance in early and late presenters. Example MI3 thresholds identifying low- and high-risk patients in the training set were 1.6 and 49.7, respectively. In the test set, MI3 values were <1.6 in 69.5% with a negative predictive value of 99.7% (99.5-99.8%) and sensitivity of 97.8% (96.7-98.7%), and were ≥49.7 in 10.6% with a positive predictive value of 71.8% (68.9-75.0%) and specificity of 96.7% (96.3-97.1%). Using these thresholds, MI3 performed better than the European Society of Cardiology 0/3-hour pathway (sensitivity, 82.5% [74.5-88.8%]; specificity, 92.2% [90.7-93.5%]) and the 99th percentile at any time point (sensitivity, 89.6% [87.4-91.6%]); specificity, 89.3% [88.6-90.0%]).

Conclusions: Using machine learning, MI3 provides an individualized and objective assessment of the likelihood of myocardial infarction, which can be used to identify low- and high-risk patients who may benefit from earlier clinical decisions.

Clinical trial registration: URL: https://www.anzctr.org.au. Unique identifier: ACTRN12616001441404.

Keywords: acute coronary syndrome; machine learning; myocardial infarction; troponin.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Calibration and discrimination of the myocardial-ischemic-injury-index (MI3) algorithm. Calibration of the MI3 algorithm with the observed proportion of patients with type 1 myocardial infarction in the test data set (A). Each point represents 100 patients. The dashed lines represent perfect calibration. Receiver operating characteristic curve showing discrimination of the MI3 algorithm in the test data set (B). Some MI3 values shown for illustrative purposes only.
Figure 2.
Figure 2.
Performance of the myocardial-ischemic-injury-index (MI3) algorithm compared with the European Society of Cardiology (ESC) 3-hour algorithm. Performance of MI3 at example thresholds (A) and the ESC 3-hour algorithm (B) for high-sensitivity cardiac troponin I (hs-cTnI) in 1652 patients with ≥2.5 hours between serial samples in the test set. URL indicates upper reference limit.
Figure 3.
Figure 3.
Performance of the myocardial-ischemic-injury-index (MI3) algorithm compared with the European Society of Cardiology (ESC) 1-hour algorithm. Performance of MI3 at sample thresholds (A) and the ESC 1-hour algorithm (B) for high-sensitivity cardiac troponin I (hs-cTnI) in 336 patients with >0.5 hour but ≤1.5 hours between serial samples in the test set.
Figure 4.
Figure 4.
Myocardial-ischemic-injury-index (MI3) clinical decision support tool to estimate the likelihood of myocardial infarction for individual patients. The figure shows a mockup of how the MI3 algorithm may be presented to physicians and patients. The top row illustrates a low-risk patient, the middle row illustrates an intermediate-risk patient, and the bottom row illustrates a high-risk patient, using the sample MI3 values of 0.9, 8.2, and 68.2, respectively. The screens on the left are for data input and return the MI3 value and estimated diagnostic metrics for an individual patient. A screen swipe presents the data in a natural frequency number and graphical format for the patient.

References

    1. Sandoval Y, Smith SW, Apple FS. Present and future of cardiac troponin in clinical practice: a paradigm shift to high-sensitivity assays. Am J Med. 2016;129:354–365. doi: 10.1016/j.amjmed.2015.12.005. - PubMed
    1. Hollander JE, Than M, Mueller C. State-of-the-art evaluation of emergency department patients presenting with potential acute coronary syndromes. Circulation. 2016;134:547–564. doi: 10.1161/CIRCULATIONAHA.116.021886. - PubMed
    1. Westermann D, Neumann JT, Sörensen NA, Blankenberg S. High-sensitivity assays for troponin in patients with cardiac disease. Nat Rev Cardiol. 2017;386:1. - PubMed
    1. Apple FS, Sandoval Y, Jaffe AS, Ordonez-Llanos J IFCC Task Force on Clinical Applications of Cardiac Bio-Markers. Cardiac troponin assays: guide to understanding analytical characteristics and their impact on clinical care. Clin Chem. 2017;63:73–81. doi: 10.1373/clinchem.2016.255109. - PubMed
    1. Thygesen K, Alpert JS, Jaffe AS, Simoons ML, Chaitman BR. ESC/ACCF/AHA/WHF expert consensus document: third universal definition of myocardial infarction. Circulation. 2012;126:2020–2035. doi: 10.1161/CIR.0b013e31826e1058. - PubMed